BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19797525)

  • 1. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.
    Ye Z; Zhan H; Mali P; Dowey S; Williams DM; Jang YY; Dang CV; Spivak JL; Moliterno AR; Cheng L
    Blood; 2009 Dec; 114(27):5473-80. PubMed ID: 19797525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.
    Ye Z; Liu CF; Lanikova L; Dowey SN; He C; Huang X; Brodsky RA; Spivak JL; Prchal JT; Cheng L
    Stem Cells; 2014 Jan; 32(1):269-78. PubMed ID: 24105986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.
    Dorn I; Klich K; Arauzo-Bravo MJ; Radstaak M; Santourlidis S; Ghanjati F; Radke TF; Psathaki OE; Hargus G; Kramer J; Einhaus M; Kim JB; Kögler G; Wernet P; Schöler HR; Schlenke P; Zaehres H
    Haematologica; 2015 Jan; 100(1):32-41. PubMed ID: 25326431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease.
    Uchida N; Haro-Mora JJ; Fujita A; Lee DY; Winkler T; Hsieh MM; Tisdale JF
    Stem Cells; 2017 Mar; 35(3):586-596. PubMed ID: 27739611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
    Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
    Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
    Yamamoto S; Otsu M; Matsuzaka E; Konishi C; Takagi H; Hanada S; Mochizuki S; Nakauchi H; Imai K; Tsuji K; Ebihara Y
    PLoS One; 2015; 10(3):e0120841. PubMed ID: 25803811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors.
    Niwa A; Heike T; Umeda K; Oshima K; Kato I; Sakai H; Suemori H; Nakahata T; Saito MK
    PLoS One; 2011; 6(7):e22261. PubMed ID: 21818303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.
    Husa AM; Strobl MR; Strajeriu A; Wieser M; Strehl S; Fortschegger K
    Stem Cells Dev; 2018 Oct; 27(19):1376-1384. PubMed ID: 30009677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.
    Park TS; Zimmerlin L; Zambidis ET
    Cytometry A; 2013 Jan; 83(1):114-26. PubMed ID: 22736485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients.
    Saliba J; Hamidi S; Lenglet G; Langlois T; Yin J; Cabagnols X; Secardin L; Legrand C; Galy A; Opolon P; Benyahia B; Solary E; Bernard OA; Chen L; Debili N; Raslova H; Norol F; Vainchenker W; Plo I; Di Stefano A
    PLoS One; 2013; 8(9):e74257. PubMed ID: 24066127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs.
    Fujita A; Uchida N; Haro-Mora JJ; Winkler T; Tisdale J
    Stem Cells; 2016 Jun; 34(6):1541-52. PubMed ID: 26866725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
    Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
    Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutation.
    Boehnke J; Atakhanov S; Toledo MAS; Schüler HM; Sontag S; Chatain N; Koschmieder S; Brümmendorf TH; Kramann R; Zenke M
    Stem Cell Res; 2021 Aug; 55():102490. PubMed ID: 34391098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
    Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
    Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms.
    Liu C; Imai M; Edahiro Y; Mano S; Takei H; Nudejima M; Kurose A; Morishita S; Ando M; Tsuneda S; Araki M; Komatsu N
    Exp Hematol; 2023 Feb; 118():12-20. PubMed ID: 36511286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
    Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.
    Ye Z; Cheng L
    Regen Med; 2010 Jul; 5(4):521-30. PubMed ID: 20632856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.